| 7th Feb 2022 10:30 am |
RNS |
Publication of full year 2021 results: Replacement |
| 7th Feb 2022 10:00 am |
RNS |
Publication of full year 2021 results |
| 2nd Feb 2022 7:00 am |
RNS |
GSK announces settlement between ViiV and Gilead |
| 1st Feb 2022 1:44 pm |
RNS |
FDA approves ViiV Healthcare’s sNDA for Cabenuva |
| 1st Feb 2022 11:44 am |
RNS |
Total Voting Rights |
| 26th Jan 2022 4:48 pm |
RNS |
Director/PDMR Shareholding |
| 20th Jan 2022 3:59 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2022 4:33 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2022 3:14 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2022 3:10 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2022 7:00 am |
RNS |
Tony Wood appointed CSO Designate, GSK |
| 17th Jan 2022 5:04 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jan 2022 3:07 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jan 2022 7:00 am |
RNS |
Update - GSK Consumer Healthcare |
| 14th Jan 2022 3:22 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2022 4:12 pm |
RNS |
Director/PDMR Shareholding |
| 11th Jan 2022 4:28 pm |
RNS |
Director/PDMR Shareholding |
| 11th Jan 2022 12:08 pm |
RNS |
US Govt buys additional 600,000 sotrovimab doses |
| 4th Jan 2022 12:28 pm |
RNS |
Total Voting Rights |
| 23rd Dec 2021 1:11 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Dec 2021 2:57 pm |
RNS |
Director/PDMR Shareholding |
| 21st Dec 2021 7:00 am |
RNS |
ViiV Healthcare announces FDA approval of Apretude |
| 20th Dec 2021 7:00 am |
RNS |
Consumer Healthcare Chair Designate appointed |
| 17th Dec 2021 12:48 pm |
RNS |
Xevudy approved in Europe to treat COVID-19 |
| 15th Dec 2021 7:00 am |
RNS |
GSK/Sanofi COVID-19 vaccine booster & Ph3 update |
| 13th Dec 2021 11:25 am |
RNS |
Director/PDMR Shareholding |
| 9th Dec 2021 4:35 pm |
RNS |
Director/PDMR Shareholding |
| 7th Dec 2021 12:00 pm |
RNS |
Medicago/GSK COVID-19 vaccine positive Ph3 data |
| 7th Dec 2021 7:07 am |
RNS |
Sotrovimab retains its activity vs Omicron variant |
| 2nd Dec 2021 7:02 am |
RNS |
Sotrovimab retains its activity vs Omicron variant |
| 1st Dec 2021 11:05 am |
PRN |
Total Voting Rights |
| 24th Nov 2021 4:17 pm |
RNS |
Director/PDMR Shareholding |
| 24th Nov 2021 4:00 pm |
RNS |
GSK publishes provisional 2022 dividend dates |
| 23rd Nov 2021 3:06 pm |
RNS |
Director/PDMR Shareholding |
| 17th Nov 2021 7:00 am |
RNS |
Nucala approved in Europe for more indications |
| 15th Nov 2021 4:37 pm |
RNS |
Block listing Interim Review |
| 12th Nov 2021 12:00 pm |
RNS |
Phase III IM administration data for sotrovimab |
| 12th Nov 2021 9:23 am |
RNS |
Director/PDMR Shareholding |
| 10th Nov 2021 11:28 am |
RNS |
Director/PDMR Shareholding |
| 5th Nov 2021 5:33 pm |
RNS |
GSK shares positive Phase III data for daprodustat |
